Docstoc

An Injectable Hydrogel for Nucleus Pulposis Augmentation

Document Sample
An Injectable Hydrogel for Nucleus Pulposis Augmentation Powered By Docstoc
					           An Injectable Hydrogel for Nucleus
                Pulposus Augmentation




                   Cambridge Polymer Group, Inc.
                   52-R Roland St., Boston, MA 02129
3/5/2004           (617) 629-4400 www.campoly.com
Anatomy of the Spine
•   Composite Structure
     –     Bony vertebral bodies

     –     Intervertebral Disc

•   Intervertebral disc (IVD)
     –     Outer multilayer fiber structure (annulus
           fibrosus, AF)

     –     Jelly-like inner core, 80% water (nucleus
           pulposus, NP)

•   Notes
     –     Nutrient flow out of vascularized vertebrae is
           through faceplates
             •   Diffuses through NP

     –     Annulus Fibrosis is innervated on outside
                                                            NP
           layers only




3/5/2004                                                         AF
Background
•     Lower back pain
       – Herniations
       – Degenerated discs/Trauma
               • Loss of disc height
               • Tears in annulus fibrosus
•     Treatments
       – Discectomies: most common surgical procedures
         for treating intervertebral disc herniation
       – Fusion
       – Disc replacement
•     Loss of nucleus pulposus decreases disc
      height, observed in 98% of discectomy patients
       –   Increases load on facet joints
       –   Deterioration of facet cartilage
       –   Bulging of annulus fibrosus
       –   All result in pain



    3/5/2004
Disc Repair


•   Restoration of disc height and
    distribution of load across
    vertebral surfaces and annulus
    fibrosus
•   Two approaches to disc repair:
    – Total disc replacement
    – Nucleus pulposus augmentation




3/5/2004
Nucleus Augmentation: In Situ vs. External
Fabrication

•   Minimizes damage to annulus fibrosus (AF)
     – Better load transfer of NP to AF
           • “flat tire”
•   Better load distribution
     – NP conforms to vertebral surfaces in joint
       space, avoid point or line contact loads
           • mimics behavior of natural NP
•   Less chance of expulsion
     – Better lock-and-key approach
           • Fully fills old NP void
•   Minimally invasive surgery
     – Early therapy, which can be easily revised
       with fusion or total IVD replacement         Line contacts



3/5/2004
Invention Summary

•   CPG has developed a technique to
    control the gelation kinetics of vinyl
    polymers, allowing injection of a pre-gel
    mixture into a joint space, followed by in
    situ gelation, forming a load-bearing
    hydrogel


•   The parameter space allows a range of
    hydrogels with tunable mechanical
    properties and gelation times




3/5/2004
Basics of Invention

 •   The rate of gelation of aqueous vinyl polymers is controlled
     with a second gelling agent (gellant)
 •   Yields a gelling polymer with a finite working time
       – Remains in a viscoelastic state for minutes to hours
       – Injected, molded, extruded, calendered, etc.
 •   The material starts as a two-part mixture
       – Mixed in a mixer, then injected
       – Mixed with a two barrel syringe during injection
 •   Patent pending




3/5/2004
Basics of Invention (continued)
•   Gelation occurs over a controlled
    time scale
     – 5 minutes to several hours
•   Actively working with a range of
    gellants
     – Can control
           • Gelation time
           • Pore structure
           • Mechanical properties
•   Emphasis on biocompatible
    materials
     – No polymerization occurs
•   No toxic residues will be released



3/5/2004
Advantages of Technology

•   In Situ fabrication of implants
•   FDA clearance likely
     – All materials are biocompatible
     – No by-products produced in hydrogel formation
•   Tunable range of mechanical properties
•   Tunable range of gelation times
•   Closure plug at joint injection site can be created by
    contacting injected pre-gel mixture with high concentration
    gellant




3/5/2004
For More Information




           Contact:

                  Cambridge Polymer Group, Inc.
                  52-R Roland St.
                  Boston, MA 02129
                  (617) 629-4400
                  info@campoly.com
                  www.campoly.com




3/5/2004

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:7
posted:8/23/2011
language:English
pages:10